October 31st 2024
In an interview with Targeted Oncology, Josep Maria Ribera, MD, PhD, discussed the evolving treatment protocols for Philadelphia chromosome-positive acute lymphoblastic leukemia.
September 24th 2024
KRd-ASCT Improves Long-Term PFS in Multiple Myeloma
October 3rd 2021Promising survival results were shown in the FORTE trial of carfilzomib plus lenalidomide, and dexamethasone induction/consolidation with autologous stem cell transplant and maintenance with carfilzomib-lenalidomide in patients with multiple myeloma.
Read More
Prolonged Reponses Following ASCT and Standard Consolidation/Induction With Daratumumab Maintenance
June 20th 2021Benefit was seen with daratumumab maintenance therapy for patients with newly diagnosed multiple myeloma who received autologous stem cell transplant plus induction and consolidation therapy with bortezomib, thalidomide, and dexamethasone.
Read More